Theresa H. Benezeder

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

BHLHE40/DEC1 programs epidermal Langerhans cell identity.

BHLHE40/DEC1 programs epidermal Langerhans cell identity.

Journal: The Journal of investigative dermatology

Published: March 02, 2026

Reply.

Reply.

Journal: The Journal of allergy and clinical immunology

Published: November 17, 2025

Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment.

Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment.

Journal: Journal of dermatological science

Published: January 30, 2025

IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP).

IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP).

Journal: The Journal of allergy and clinical immunology

Published: November 18, 2024

Langerhans cells: Central players in the pathophysiology of atopic dermatitis.

Langerhans cells: Central players in the pathophysiology of atopic dermatitis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 24, 2024

Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice.

Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice.

Journal: The Journal of investigative dermatology

Published: March 18, 2024

Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis.

Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis.

Journal: Research square

Published: February 27, 2024

Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.

Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.

Journal: The Journal of investigative dermatology

Published: June 01, 2023

BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

BRAFV600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

Journal: Leukemia

Published: May 02, 2023

Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.

Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.

Journal: The Journal of investigative dermatology

Published: July 13, 2022

Central memory T cells are the most effective precursors of resident memory T cells in human skin.

Central memory T cells are the most effective precursors of resident memory T cells in human skin.

Journal: Science immunology

Published: April 22, 2022

Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.

Induction of IL-1β and antimicrobial peptides as a potential mechanism for topical dithranol.

Journal: Experimental dermatology

Published: November 23, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026